CommercialAdministrativeLow impact
07.11.02f, Measurement of Exhaled Nitric Oxide and Breath Condensate in the Diagnosis and Management of Asthma and Other Respiratory Disorders
Independence Blue Cross·Pulmonology, Allergy & Immunology, Family Medicine +2 more·Medical Policy
Effective date
Oct 1, 2025
We identified it
Jun 19, 2026
Summary
Independence Blue Cross has reissued policy 07.11.02f regarding measurement of exhaled nitric oxide and breath condensate for asthma and respiratory disorder diagnosis and management. This is a commercial policy reissue with no indication of substantive changes to coverage or billing requirements.
Action Required
No immediate action required. This appears to be an administrative reissue of an existing policy. Monitor for any updated policy documents that may contain specific coverage or billing changes when they become available.